Evidence map›Paper›PMID 12960422›Full record

ArticleMolecular biology of the cell2003

Genetic and biochemical evaluation of the importance of Cdc6 in regulating mitotic exit.

Vincent Archambault, Caihong X Li, Alan J Tackett, Ralph Wasch, Brian T Chait, Michael P Rout, Frederick R Cross

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A mass spectrometry view of stable and transient protein interactions.Advances in experimental medicine and biology · 2014
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Resolving the composition of protein complexes using a MALDI LTQ Orbitrap.Journal of the American Society for Mass Spectrometry · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vincent ArchambaultThe Rockefeller University, New York, New York 10021, USA.
Caihong X Li
Alan J Tackett
Ralph Wasch
Brian T Chait
Michael P Rout
Frederick R Cross
Rockefeller University · US

Funding

SPECIFICITY OF CYCLIN FUNCTION AT CELL CYCLE INITIATIONR01GM047238 · NIGMS · ROCKEFELLER UNIVERSITY · PI CROSS, FREDERICK R. · 1993 to 2010
$3.4M
COMPREHENSIVE MAP OF CELLULAR PROTEIN INTERACTIONSR33CA089810 · NCI · ROCKEFELLER UNIVERSITY · PI CHAIT, BRIAN T · 2001 to 2003
$1.8M
NCI NIH HHS CA-89810NCI NIH HHS R33 CA089810NIGMS NIH HHS GM-47238NIGMS NIH HHS R01 GM047238
6 · The paper itself

Abstract

We evaluated the hypothesis that the N-terminal region of the replication control protein Cdc6 acts as an inhibitor of cyclin-dependent kinase (Cdk) activity, promoting mitotic exit. Cdc6 accumulation is restricted to the period from mid-cell cycle until the succeeding G1, due to proteolytic control that requires the Cdc6 N-terminal region. During late mitosis, Cdc6 is present at levels comparable with Sic1 and binds specifically to the mitotic cyclin Clb2. Moderate overexpression of Cdc6 promotes viability of CLB2Deltadb strains, which otherwise arrest at mitotic exit, and rescue is dependent on the N-terminal putative Cdk-inhibitory domain. These observations support the potential for Cdc6 to inhibit Clb2-Cdk, thus promoting mitotic exit. Consistent with this idea, we observed a cytokinesis defect in cdh1Delta sic1Delta cdc6Delta2-49 triple mutants. However, we were able to construct viable strains, in three different backgrounds, containing neither SIC1 nor the Cdc6 Cdk-inhibitory domain, in contradiction to previous work. We conclude, therefore, that although both Cdc6 and Sic1 have the potential to facilitate mitotic exit by inhibiting Clb2-Cdk, mitotic exit nevertheless does not require any identified stoichiometric inhibitor of Cdk activity.

Indexed as

Cell CycleCell Cycle ProteinsCell SurvivalCyclin BCyclin-Dependent Kinase Inhibitor ProteinsMass SpectrometryMitosisProtein BindingProtein Structure, TertiarySaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCDC6 protein, S cerevisiaeCell Cycle ProteinsCLB2 protein, S cerevisiaeCyclin BCyclin-Dependent Kinase Inhibitor ProteinsSaccharomyces cerevisiae ProteinsSIC1 protein, S cerevisiae

Identifiers

PMID12960422
PMCPMC313736
OpenAlexW2105026768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.